Biogen-IDEC (BIIB +4.1%) closes at the top of the S&P leader board after ISI Group ups it to...

|About: Biogen Inc. (BIIB)|By:, SA News Editor

Biogen-IDEC (BIIB +4.1%) closes at the top of the S&P leader board after ISI Group ups it to Buy, citing a strong pipeline, and noting its new BG-12 multiple-sclerosis pill can double earnings over the next three to four years.